In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
After the withdrawal of the Taliban in Afghanistan, the resilient attitude of some countries towa
Lucknow Super Giants suffered a major blow in IPL 2023 when captain KL Rahul was ruled out of the
The Congress party paid tribute to former Prime Minister Indira Gandhi on her death anniversary o
41 lives are still at stake in the Silkyara Tunnel accident of Uttarkashi. For the last 10 days,
UP and Haryana police are on alert regarding farmers' march to Delhi. Security arrangements are s
Earthquake in eastern Indonesia: 5.8 magnitude jolts houses, beach evacuation warnings
A 5.8-magnitude earthquake struck eastern Indonesia on Wednesday, causing cracks in some walls, a
Tensions between Russia and Ukraine and the price of precious metals caught fire soon after Russi
The first semi-final of the T20 World Cup 2022 will be played between Pakistan and New Zealand at
Things are slowly becoming normal in Kolhapur, Maharashtra. Most of the shops were seen open in t
Women of Delhi will not have to do much for Rs 2500 every month. Delhi's nominated Chief Minister
